Azithromycin for the prevention of rehospitalisation and death among Kenyan children being discharged from hospital: a double-blind, placebo-controlled, randomised controlled trial

Azithromycin for the prevention of rehospitalisation and death among Kenyan children being discharged from hospital: a double-blind, placebo-controlled, randomised controlled trial

Summary: Background: Mass drug administration of azithromycin to children in sub-Saharan Africa has been shown to improve survival in high-mortality settings. The period after hospital discharge is a time of elevated risk unaddressed by current interventions and might provide an opportunity for tar...

Full description

Bibliographic Details
Main Authors: Patricia B Pavlinac, PhD, Benson O Singa, MBChB, Kirkby D Tickell, MBBS, Rebecca L Brander, PhD, Christine J McGrath, PhD, Mary Amondi, BA, Joyce Otieno, DIP, Elizabeth Akinyi, BSc, Doreen Rwigi, BSc, Joseph D Carreon, MS, Stephanie N Tornberg-Belanger, MPH, Ruth Nduati, MMed, Joseph B Babigumira, PhD, Liru Meshak, MBChB, George Bogonko, MMed, Samuel Kariuki, PhD, Barbra A Richardson, PhD, Grace C John-Stewart, MD, Judd L Walson, MD
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X21003478

Internet

http://www.sciencedirect.com/science/article/pii/S2214109X21003478

Similar Items